The "early feasibility" open-label study will also test the safety and efficacy of Neuralink's R1 robot that is used to implant the thread-like electrodes used in the BCI into the brain.

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

(Reuters) -Elon Musk's brain implant company Neuralink is planning to raise about $500 million at a pre-money valuation of $8.5 billion, Bloomberg News reported on Wednesday, citing people with ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...